Welcome to a UBI House breakfast & seminar at Tvistevägen 48, in conference room “Skogen”.
Speaker: Peter Hovstadius, Chief Medical Officer (CMO) at Lipum AB.
Seminar: “Insights from Lipum’s Phase I Trial – Early Data and Future Potential”.
Peter Hovstadius shares insights from the Phase 1-trial with Lipum’s drug candidate SOL-116.
About: Peter Hovstadius is a specialist in clinical pharmacology with a PhD in drug development from Uppsala University. He has a long career in both the pharmaceutical industry and academia.
Registration deadline: Thursday, September 11. After this, you can sign up for the seminar, but not for breakfast.
NOTE: The event is open to everyone. UBI offers breakfast from 8.00, and the seminar starts at 8:15.
